Replies to post #793 on Lotus Pharmaceuticals Inc (LTUS)

[cliffvb]

Q3 is now out. EPS was 4c diluted vs 6c the previous Q. Lower but much better than a loss which I was concerned we might see. Also cash flow from operations at $3.9 mil actually increased from Q2 of 3.05 mil. Certainly cheap compared to mkt cap of only $9 mil.

http://secfilings.com/searchresultswide.aspx?TabIndex=2&FilingID=8235571&companyid=648966&ppu=%252fDefault.aspx%253fformgroupid%253d2%2526amp%253bauth%253d1%2526amp%253bticker%253dLTUS